Copyright Reports & Markets. All rights reserved.

Global Mesenchymal Stem Cells Market Size, Status and Forecast 2019-2025

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Key Market Segments
    • 1.3 Players Covered
    • 1.4 Market Analysis by Type
      • 1.4.1 Global Mesenchymal Stem Cells Market Size Growth Rate by Type (2014-2025)
      • 1.4.2 Human MSC
      • 1.4.3 Mouse MSC
      • 1.4.4 Rat MSC
      • 1.4.5 Other
    • 1.5 Market by Application
      • 1.5.1 Global Mesenchymal Stem Cells Market Share by Application (2014-2025)
      • 1.5.2 Research Institute
      • 1.5.3 Hospital
      • 1.5.4 Others
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Global Growth Trends

    • 2.1 Mesenchymal Stem Cells Market Size
    • 2.2 Mesenchymal Stem Cells Growth Trends by Regions
      • 2.2.1 Mesenchymal Stem Cells Market Size by Regions (2014-2025)
      • 2.2.2 Mesenchymal Stem Cells Market Share by Regions (2014-2019)
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers
      • 2.3.3 Market Opportunities

    3 Market Share by Key Players

    • 3.1 Mesenchymal Stem Cells Market Size by Manufacturers
      • 3.1.1 Global Mesenchymal Stem Cells Revenue by Manufacturers (2014-2019)
      • 3.1.2 Global Mesenchymal Stem Cells Revenue Market Share by Manufacturers (2014-2019)
      • 3.1.3 Global Mesenchymal Stem Cells Market Concentration Ratio (CR5 and HHI)
    • 3.2 Mesenchymal Stem Cells Key Players Head office and Area Served
    • 3.3 Key Players Mesenchymal Stem Cells Product/Solution/Service
    • 3.4 Date of Enter into Mesenchymal Stem Cells Market
    • 3.5 Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Type and Application

    • 4.1 Global Mesenchymal Stem Cells Market Size by Type (2014-2019)
    • 4.2 Global Mesenchymal Stem Cells Market Size by Application (2014-2019)

    5 United States

    • 5.1 United States Mesenchymal Stem Cells Market Size (2014-2019)
    • 5.2 Mesenchymal Stem Cells Key Players in United States
    • 5.3 United States Mesenchymal Stem Cells Market Size by Type
    • 5.4 United States Mesenchymal Stem Cells Market Size by Application

    6 Europe

    • 6.1 Europe Mesenchymal Stem Cells Market Size (2014-2019)
    • 6.2 Mesenchymal Stem Cells Key Players in Europe
    • 6.3 Europe Mesenchymal Stem Cells Market Size by Type
    • 6.4 Europe Mesenchymal Stem Cells Market Size by Application

    7 China

    • 7.1 China Mesenchymal Stem Cells Market Size (2014-2019)
    • 7.2 Mesenchymal Stem Cells Key Players in China
    • 7.3 China Mesenchymal Stem Cells Market Size by Type
    • 7.4 China Mesenchymal Stem Cells Market Size by Application

    8 Japan

    • 8.1 Japan Mesenchymal Stem Cells Market Size (2014-2019)
    • 8.2 Mesenchymal Stem Cells Key Players in Japan
    • 8.3 Japan Mesenchymal Stem Cells Market Size by Type
    • 8.4 Japan Mesenchymal Stem Cells Market Size by Application

    9 Southeast Asia

    • 9.1 Southeast Asia Mesenchymal Stem Cells Market Size (2014-2019)
    • 9.2 Mesenchymal Stem Cells Key Players in Southeast Asia
    • 9.3 Southeast Asia Mesenchymal Stem Cells Market Size by Type
    • 9.4 Southeast Asia Mesenchymal Stem Cells Market Size by Application

    10 India

    • 10.1 India Mesenchymal Stem Cells Market Size (2014-2019)
    • 10.2 Mesenchymal Stem Cells Key Players in India
    • 10.3 India Mesenchymal Stem Cells Market Size by Type
    • 10.4 India Mesenchymal Stem Cells Market Size by Application

    11 Central & South America

    • 11.1 Central & South America Mesenchymal Stem Cells Market Size (2014-2019)
    • 11.2 Mesenchymal Stem Cells Key Players in Central & South America
    • 11.3 Central & South America Mesenchymal Stem Cells Market Size by Type
    • 11.4 Central & South America Mesenchymal Stem Cells Market Size by Application

    12 International Players Profiles

    • 12.1 Lonza
      • 12.1.1 Lonza Company Details
      • 12.1.2 Company Description and Business Overview
      • 12.1.3 Mesenchymal Stem Cells Introduction
      • 12.1.4 Lonza Revenue in Mesenchymal Stem Cells Business (2014-2019)
      • 12.1.5 Lonza Recent Development
    • 12.2 Thermo Fisher
      • 12.2.1 Thermo Fisher Company Details
      • 12.2.2 Company Description and Business Overview
      • 12.2.3 Mesenchymal Stem Cells Introduction
      • 12.2.4 Thermo Fisher Revenue in Mesenchymal Stem Cells Business (2014-2019)
      • 12.2.5 Thermo Fisher Recent Development
    • 12.3 Bio-Techne
      • 12.3.1 Bio-Techne Company Details
      • 12.3.2 Company Description and Business Overview
      • 12.3.3 Mesenchymal Stem Cells Introduction
      • 12.3.4 Bio-Techne Revenue in Mesenchymal Stem Cells Business (2014-2019)
      • 12.3.5 Bio-Techne Recent Development
    • 12.4 ATCC
      • 12.4.1 ATCC Company Details
      • 12.4.2 Company Description and Business Overview
      • 12.4.3 Mesenchymal Stem Cells Introduction
      • 12.4.4 ATCC Revenue in Mesenchymal Stem Cells Business (2014-2019)
      • 12.4.5 ATCC Recent Development
    • 12.5 MilliporeSigma
      • 12.5.1 MilliporeSigma Company Details
      • 12.5.2 Company Description and Business Overview
      • 12.5.3 Mesenchymal Stem Cells Introduction
      • 12.5.4 MilliporeSigma Revenue in Mesenchymal Stem Cells Business (2014-2019)
      • 12.5.5 MilliporeSigma Recent Development
    • 12.6 PromoCell GmbH
      • 12.6.1 PromoCell GmbH Company Details
      • 12.6.2 Company Description and Business Overview
      • 12.6.3 Mesenchymal Stem Cells Introduction
      • 12.6.4 PromoCell GmbH Revenue in Mesenchymal Stem Cells Business (2014-2019)
      • 12.6.5 PromoCell GmbH Recent Development
    • 12.7 Genlantis
      • 12.7.1 Genlantis Company Details
      • 12.7.2 Company Description and Business Overview
      • 12.7.3 Mesenchymal Stem Cells Introduction
      • 12.7.4 Genlantis Revenue in Mesenchymal Stem Cells Business (2014-2019)
      • 12.7.5 Genlantis Recent Development
    • 12.8 Celprogen
      • 12.8.1 Celprogen Company Details
      • 12.8.2 Company Description and Business Overview
      • 12.8.3 Mesenchymal Stem Cells Introduction
      • 12.8.4 Celprogen Revenue in Mesenchymal Stem Cells Business (2014-2019)
      • 12.8.5 Celprogen Recent Development
    • 12.9 Cell Applications
      • 12.9.1 Cell Applications Company Details
      • 12.9.2 Company Description and Business Overview
      • 12.9.3 Mesenchymal Stem Cells Introduction
      • 12.9.4 Cell Applications Revenue in Mesenchymal Stem Cells Business (2014-2019)
      • 12.9.5 Cell Applications Recent Development
    • 12.10 Cyagen Biosciences
      • 12.10.1 Cyagen Biosciences Company Details
      • 12.10.2 Company Description and Business Overview
      • 12.10.3 Mesenchymal Stem Cells Introduction
      • 12.10.4 Cyagen Biosciences Revenue in Mesenchymal Stem Cells Business (2014-2019)
      • 12.10.5 Cyagen Biosciences Recent Development

    13 Market Forecast 2019-2025

    • 13.1 Market Size Forecast by Regions
    • 13.2 United States
    • 13.3 Europe
    • 13.4 China
    • 13.5 Japan
    • 13.6 Southeast Asia
    • 13.7 India
    • 13.8 Central & South America
    • 13.9 Market Size Forecast by Product (2019-2025)
    • 13.10 Market Size Forecast by Application (2019-2025)

    14 Analyst's Viewpoints/Conclusions

      15 Appendix

      • 15.1 Research Methodology
        • 15.1.1 Methodology/Research Approach
          • 15.1.1.1 Research Programs/Design
          • 15.1.1.2 Market Size Estimation
          • 12.1.1.3 Market Breakdown and Data Triangulation
        • 15.1.2 Data Source
          • 15.1.2.1 Secondary Sources
          • 15.1.2.2 Primary Sources
      • 15.2 Disclaimer

      Mesenchymal Stem Cells (MSC), also termed Mesenchymal Stromal Cells, are multipotent cells that can differentiate into a variety of cell types and have the capacity for self-renewal. MSC have been shown to differentiate in vitro or in vivo into adipocytes, chondrocytes, osteoblasts, myocytes, neurons, hepatocytes, and pancreatic islet cells. Optimized PromoCell media are available to support both the growth of MSC and their differentiation into several different lineages. Recent experiments suggest that differentiation capabilities into diverse cell types vary between MSC of different origin.
      In the last several years, Global market of Mesenchymal Stem Cells developed rapidly, with an average growth rate of 6.2%. In 2015, Global revenue of Mesenchymal Stem Cells is about 110 M USD.
      The global average gross margin of Mesenchymal Stem Cells is in the fluctuation trend, from 70% in 2012 to 67% in 2016. With the situation of global economy, gross margin will be in decreasing trend in the following five years.
      The type of Mesenchymal Stem Cells includes Human, Mouse, Rat. The proportion of Human in 2015 is about 39%, and the proportion of Mouse in 2016 is about 31%.
      In 2018, the global Mesenchymal Stem Cells market size was 170 million US$ and it is expected to reach 250 million US$ by the end of 2025, with a CAGR of 4.5% during 2019-2025.

      This report focuses on the global Mesenchymal Stem Cells status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Mesenchymal Stem Cells development in United States, Europe and China.

      The key players covered in this study
      Lonza
      Thermo Fisher
      Bio-Techne
      ATCC
      MilliporeSigma
      PromoCell GmbH
      Genlantis
      Celprogen
      Cell Applications
      Cyagen Biosciences

      Market segment by Type, the product can be split into
      Human MSC
      Mouse MSC
      Rat MSC
      Other

      Market segment by Application, split into
      Research Institute
      Hospital
      Others

      Market segment by Regions/Countries, this report covers
      United States
      Europe
      China
      Japan
      Southeast Asia
      India
      Central & South America

      The study objectives of this report are:
      To analyze global Mesenchymal Stem Cells status, future forecast, growth opportunity, key market and key players.
      To present the Mesenchymal Stem Cells development in United States, Europe and China.
      To strategically profile the key players and comprehensively analyze their development plan and strategies.
      To define, describe and forecast the market by product type, market and key regions.

      In this study, the years considered to estimate the market size of Mesenchymal Stem Cells are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025
      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

      Buy now